Dr. Yan is responsible for Brii’s clinical development, regulatory affairs, medical affairs, drug safety, and other related functions. He is accountable for developing and driving the execution of clinical development programs and registrations.

Prior to joining the company, Dr. Yan was Vice President and Head Unit Physician of GSK Oncology, where he oversaw global development of oncology assets focusing on immunotherapy, cancer epigenetics, and cell therapy.

Dr. Yan received his medical degree from the Medical College of Peking University and a Ph.D. from the University of Kansas Medical Center. He is an adjunct professor in Yonsei University.